Cargando…

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer

PURPOSE: Immune checkpoint blockade (ICB) therapy has transformed the treatment of triple-negative breast cancer (TNBC) in recent years. However, some TNBC patients with high programmed death-ligand 1 (PD-L1) expression levels develop immune checkpoint resistance. Hence, there is an urgent need to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Ran, Wang, Yuhan, Fan, Jinyan, Tian, Ziyue, Wang, Shuang, Qin, Xiujuan, Su, Wei, Wang, Yanbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292819/ https://www.ncbi.nlm.nih.gov/pubmed/37377907 http://dx.doi.org/10.3389/fonc.2023.1108472

Ejemplares similares

Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer
por: Bao, Bowen, et al.
Publicado: (2019)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
por: Peng, Wenting, et al.
Publicado: (2021)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering
por: Wang,, Yuhan, et al.
Publicado: (2023)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer
por: Zhong, Min-Er, et al.
Publicado: (2022)

Identification of the Prognostic Signatures of Glioma With Different PTEN Status
por: Zhang, Pei, et al.
Publicado: (2021)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
por: Fan, Zongyao, et al.
Publicado: (2023)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021)

The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma
por: Wang, Yangyang, et al.
Publicado: (2021)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: da Silva, Jesse Lopes, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer
por: Sun, Xiaoli, et al.
Publicado: (2021)

Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
por: Zuo, Yanhua, et al.
Publicado: (2023)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma
por: Feng, Hong, et al.
Publicado: (2021)

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma
por: Li, Jia, et al.
Publicado: (2021)

Identification of a centrosome-related prognostic signature for breast cancer
por: Fang, Zhou, et al.
Publicado: (2023)

Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA–lncRNA Signatures and Risk of Tumor Recurrence
por: Li, Jia-wei, et al.
Publicado: (2021)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature
por: Qin, Yan, et al.
Publicado: (2021)

Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy
por: Wu, Jie, et al.
Publicado: (2021)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer
por: Liu, Meiliang, et al.
Publicado: (2020)

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0b83q60qak0a3n406sdl0po8b4